NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Impact of blood volume, tube shaking, and incubation time on reproducibility of QuantiFERON-TB gold in-tube assay.

Author(s): Gaur RL, Pai M, Banaei N

Publication: J Clin Microbiol, 2013, Vol. 51, Page 3521-6

PubMed ID: 23966505 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of blood volume, tube shaking, and duration of incubation on determination of tuberculosis (TB) response.

Conclusion of Paper

Significantly higher TB responses were measured when 0.8 mL of blood was assayed than when 1.0 or 1.2 mL was assayed, and this resulted in a higher sensitivity. Only 88.2% of the infected individuals with prior positive skin tests showed positive results using ELISA at the best volume (0.8 mL blood volume). Vigorous shaking of specimens led to significantly increased gamma interferon (IFN-gamma) levels in both nil (control) and QuantiFERON-TB Gold In-Tubes (QFT-GIT) compared to gentle inversion, but TB responses (the nil results subtracted from the QFT-GIT results) were only significantly altered if the response was calculated using a QFT-GIT and a nil tube that were mixed in different ways. In general, incubation times at 37 degrees C of 16-24 h did not affect TB responses or proportions of positive results among specimens from infected or uninfected individuals.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of blood volume, tube shaking, and duration of incubation on the sensitivity and specificity of the IFN-gamma ELISA determination of TB response. In addition, the effects of drawing specimens directly into assay tubes on specimen volume were evaluated, and TB skin test results were compared with ELISA results. Specimens were obtained from 33 uninfected individuals and 17 individuals infected with latent tuberculosis. Specimens were collected in 10 mL Monoject tubes, and blood was transferred to QFT-GIT or nil tubes (control), but a subset of 30 specimens were collected directly into the QFT-GIT and nil tubes. The control conditions for QFT-GIT testing included a blood volume of 1.0 mL, gentle inversion of tubes 10 times, and incubation at 37 degrees C for 24 h. After these procedures (or experimental variations), plasma was separated and held at room temperature for up to 8 h before assaying.

    Summary of Findings:

    The QFT-GIT and nil Vacutainer tubes were determined to have draw volumes of 0.785-1.0 mL and 0.810-1.010 mL, respectively. For specimens from uninfected volunteers, significantly higher TB responses were measured when 0.8 mL of blood was assayed than when 1.0 or 1.2 mL was assayed (p=0.03 and p=0.04, respectively), however, the percentage of positive results were not significantly different between blood volumes, although there was one false positive result at the 1.2 mL volume. For specimens from the 17 individuals with confirmed latent tuberculosis infection (positive skin test), significantly higher TB responses were also measured in 0.8 mL specimens than 1.0 or 1.2 mL specimens (p=0.002 and p<0.001, respectively), and the percentage of specimens with positive results was significantly lower for 1.2 mL specimens (10/17, 58.8%) than 0.8 mL specimens (15/17, 88.2%, p=0.05). Vigorous shaking of specimens led to significantly increased IFN-gamma levels in both nil tubes and QFT-GIT compared to gentle inversion (p<0.001 and p=0.004, respectively), but sensitivity and specificity of the TB responses (QFT-GIT levels - nil levels) were only significantly altered if the response was calculated using a QFT-GIT and a nil tube that were mixed in different ways. In general, incubation times at 37 degrees C of 16, 20, or 24 h did not affect TB responses or the sensitivity or specificity of the assay.

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Normal
    • Other diagnoses
    Platform:
    AnalyteTechnology Platform
    Protein ELISA
    Cell count/volume Macroscopic observation
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Preaquisition Diagnosis/ patient condition Latent tuberculosis
    Normal
    Biospecimen Aliquots and Components Aliquot size/volume 0.8 mL
    1.0 mL
    1.2 mL
    Biospecimen Aliquots and Components Biospecimen mixing Gentle inversion 10 times
    Vigorous shaking for 10 s
    Biospecimen Acquisition Type of collection container/solution Monoject tube
    QFT-GIT Vacutainer
    Nil Vacutainer
    Analyte Extraction and Purification Incubation duration/condition 16 h
    20 h
    24 h
    ELISA Specific Technology platform Skin test
    ELISA Specific Targeted peptide/protein IFN-gamma

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...